On 3/31/2017, Shares of Athene Holding Ltd. (NYSE:ATH) closed at $49.99 in last trading day. After noting the initial trading entry at $49.71, it reached to a day’s high of $50.80 and moved to a day’s low of $49.63. The recent daily volume was 3.17 million as contrast to it’s an average volume of 535.87 thousand.
The last close of the Athene Holding Ltd.stock reflects that it traded -2.61% from its 50-day moving average of $51.33. The stock traded above +2.27% to its 200-day MA of $48.88. Furthermore, it moved lower -9.11% from its 52-week high of $55.00 and +15.58% up from $43.25, which is 52-week low of the stock.
Athene Holding Ltd.’s (ATH) moved with shift of -1.83% in the past week. Over the last three months, the shares of the company have changed 6.11% . The stock currently has Monthly Volatility of 2.42% and Weekly Volatility of 1.84%.
March 29, 2017 Bermuda-based Athene Holding Ltd. (“Athene”) announced the pricing of an underwritten secondary offering (the “Offering”) of 27,500,000 of its Class A common shares, an increase of 2,500,000 Class A common shares from the original offering amount, at a price to the public of $48.50 per share. All of the Class A common shares are being sold by certain shareholders of Athene, and Athene will not receive any proceeds from the Offering. The underwriters have a 30-day option to purchase up to an additional 4,125,000 Class A common shares (an increase of 375,000 Class A common shares from the original offering amount) from certain of the selling shareholders at the Offering price of $48.50 per share, less the underwriting discount.
Athene’s Class A common shares on the New York Stock Exchange are listed under the symbol “ATH.”
The closing of the offering is expected to occur on April 3, 2017, subject to satisfaction of customary closing conditions.
Goldman, Sachs & Co., Barclays, Citigroup and Wells Fargo Securities are acting as joint book runners of the offering and representatives of the underwriters. Additionally, BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, Evercore ISI, Keefe, Bruyette & Woods, A Stifel Company, Sandler O’Neill + Partners, L.P., SunTrust Robinson Humphrey and UBS Investment Bank are acting as book runners of the offering.
Quorum Health Corp (NYSE:QHC) finalized the last transaction at value of $5.44, with a daily change of +1.87% or +0.10 points. The company maintained volume of 642.61 thousand shares. In past trading day, the stock hit the maximum price of $5.78 and touched to minimum value of $5.40. It has a market cap of $ 160.38M.
As of last trade close, the stock is trading downside -69.35% from its one year high of $17.75 and moved +45.07% upward from $3.75, which is one year low of the stock.
The stock traded below -32.52% from its 50-day moving average of $8.06. Furthermore, the stock moved -22.63% to its 200-day MA of $ 7.03.
During the last month, Quorum Health Corporation’s (QHC) has changed -33.90% and performed -10.53% over the last 6 months. The mean rating score for this stock is at 3.20. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 6.94% in recent month and observed Weekly Volatility of 8.66%.